BioSpace News Archive

ImmunoPrecise Antibodies Ltd. is delighted to extend an invitation to investors and other interested parties to participate in an upcoming interview hosted by Market Radius Research.

AOTI Inc. participated as a founding member of the Amputation Prevention Alliance (APA), in the " Preventing Diabetes-Related Amputations in America: A Solutions Summit,” held on Thursday, July 13, 2023 , in Washington, D.C.

The City of Hope’s highly anticipated Spirit of Life Celebration gala honoring Dr. Farouk Shami, chairman and founder of Farouk Systems, Inc., invited hundreds of esteemed beauty industry leaders to an enchanting evening of philanthropy, entertainment, and inspiration.

NovaBay ® Pharmaceuticals, Inc . announces that sales of Avenova ® -branded products reached a new record during the Amazon Prime Day event held July 11-12, 2023, with sales increasing 22% over Prime Day 2022 and 43% over Prime Day 2021.

CEL-SCI Corporation (NYSE American: CVM) today announced it has concluded a productive meeting with the U.S. Food and Drug Administration (FDA) regarding the path forward for bringing Multikine* (Leukocyte Interleukin, Injection) immunotherapy to market for the treatment of newly diagnosed locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Nemaura Medical, Inc. today provides a business update and financial results for the fiscal year ended March 31, 2023.

Nutriband Inc. today announced that it has expanded its existing Credit Line facility to $5 Million USD to fund the continued development and regulatory submission process for the Company’s patented lead product platform, AVERSA™ Fentanyl, an abuse-deterrent fentanyl transdermal system.

Galmed Pharmaceuticals Ltd. announced today that it has entered into securities purchase agreements with two institutional investors to purchase 5,600,000 of its ordinary shares (or pre-funded warrants to purchase 5,600,000 ordinary shares at a combined purchase price of $1.25 per ordinary share and accompanying warrant (the “Offering”).

Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, held an Extraordinary General Meeting.

POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top line interim results of a Phase 3 clinical trial of EuCorVac-19, a COVID-19 vaccine candidate being developed by South Korean partner EuBiologics (KOSDAQ: 206650).